CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project addresses antimicrobial resistance by developing a chemical platform for antibiotic resistance breakers. These compounds enhance the effectiveness of existing antibiotics against resistant bacteria, offering a cost-effective alternative to discovering new antibiotics and protecting pharmaceutical investmen…
We tackle the challenges posed by the emergence of antimicrobial resistance (AMR) with a conceptually new approach.
We have established a scalable chemical platform for the development of novel antibiotic resistance breakers (ARBs).
Our compounds sensitize the pathogen and restore the effectiveness of standard-of-care antibiotics.
By circumventing the painstaking process of discovering and developing new antibiotics, we bring forth a more cost-effective approach to confront the emergence of AMR.…
QURETECH BIO AB
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
